WKN DE: A1JTP0 / ISIN: JP3205350006

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Chiome Bioscience Times and Sales (TOKIO)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Chiome Bioscience Inc.

Weitere Meldungen

01:00		Here's How Much $1000 Invested In ACM Research 5 Years Ago Would Be Worth Today
01:00		Anthropic says Claude now leads a quarter of work building its next AI models
01:00		StarHub 5G upgrade may defend market share, but unlikely to reverse underlying earnings slump
01:00		From Haidilao to Oriental Kopi: How some of Asia’s favourite F&B players are faring in 2026
01:00		Warren Buffett Has More Than 50% of His Portfolio in These 3 Stocks. Which One Is the Best Buy Today?
00:47		Congratulations, World: A New Supercute Cat Species Has Been Found
00:45		Here’s How Much You Would Have Made Owning Fortinet Stock In The Last 15 Years
00:40		Why Was Micron Technology Stock Up Today?
00:39		Tesla Posted Negative $1.1 Billion in Free Cash Flow Last Quarter as Elon Musk Ramps Up Spending on Robotaxis and Optimus. Here's Why the Company's $43.5 Billion Cash Cushion Still Matters.
00:35		Bank of Japan set to raise interest rates to 31-year high
00:30		Here's How Much $1000 Invested In Installed Building Prods 10 Years Ago Would Be Worth Today
00:24		Star Bulk Director Raffaele Zagari Buys 60,000 Shares for $1.7 Million. How Bullish Is This For Investors?
00:15		Here’s How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 10 Years
00:15		iPhone 18 Pro vs. Pixel 11 Pro: The New Apple and Google Pro Phones Are Quite Different
00:12		Oil falls 1% as investors watch Middle East supply disruptions
00:11		Prediction: A $5,000 Investment Split Between Micron and Sandisk Will Triple Before 2028
00:08		Lennar (LEN) Q3 2026 Earnings Call Transcript
00:00		Here's How Much $1000 Invested In Jackson Financial 5 Years Ago Would Be Worth Today
17.09.26		Trump hails 'major progress' in setting up US base in Poland
17.09.26		ICU Medical CFO Sells 6,381 Shares for $1.1 Million
17.09.26		Borr Drilling Director Troim Buys One Million Shares in the Open Market. What Does This Mean for The Stock?
17.09.26		Here's How Much $100 Invested In Mettler-Toledo Intl 20 Years Ago Would Be Worth Today
17.09.26		Prediction: This Quantum Computing Stock Is Going to Plummet Over the Next 12 Months
17.09.26		Searing Elon Musk Film Nears U.S. Release Amid Overseas Concerns
17.09.26		DoorDash Can Now Deliver Your Ginormous Costco Order the Same Day
17.09.26		'You’re Liable For Your Own Actions': Palantir CEO Alex Karp Opens a Third Front In The AI Safety Fight
17.09.26		A GigaCloud Director Dumped 3,000 Shares After the Stock Hit a 52-Week High
17.09.26		Breville’s Eye Q Uses an Optic Sensor for Flawless Toast. Here’s My Review
17.09.26		The 10-year Treasury is having its worst run in over 100 years. Why investors are buying bonds anyway.
17.09.26		Stock Market Today, Sept. 17: Intel Surges 8% on Rumored SK Hynix Talks
17.09.26		Stock Market Today, Sept. 17: CoreWeave Falls on Convertible Debt and Share Sale Announcement
17.09.26		CBL & Associates CEO Lebovitz Sells 50,000 Shares for $2.6 Million
17.09.26		Roku Just Added More Than 30 Streaming Bundles to Help People Save Money
17.09.26		QUICK SPARK: KKR Raises 10-Year Treasury Yield Forecast To 5.1% As Higher-For-Longer Rates Loom
17.09.26		Adam Smith Named Chairman, Direct-to-Consumer, Disney Entertainment
17.09.26		Meta Platforms haftet für Werbung und Profile unter fremdem Namen
17.09.26		Ten-Year Treasury Yield Hits 5%: Why QQQ Could Face More Pressure Than Value ETFs
17.09.26		Palantir CEO Alex Karp Says Only Washington Can Cap AI Liability: 'These Businesses Have to Be Nationalized'
17.09.26		Nvidia Stock Split in 2026? My Prediction: It's Unlikely, but the Stock Is Still a Buy.
17.09.26		Meta Just Launched a New Subscription Business Built Entirely Around AI. Here's Why It Could Be a Game-Changer.
17.09.26		2 Stocks That Former CEO Warren Buffett Purchased for Berkshire Hathaway's Portfolio Now Earn Over $1.44 Billion in Annual Dividends
17.09.26		Why Paradium.AI Stock Skyrocketed Thursday: Inside the $1 Billion Deal and Complex Corporate Reunion
17.09.26		If You Invested $100 In Brinker International Stock 10 Years Ago, You Would Have This Much Today
17.09.26		Nike and Lululemon Both Hit Multi-Year Lows in September. Which Stock Is Best Positioned to Make a Comeback?
17.09.26		MoneyGram Just Launched Its First Stablecoin-Backed Visa Card. Here's What Crypto Investors Need to Know.
17.09.26		$100 Invested In CF Industries Holdings 5 Years Ago Would Be Worth This Much Today
17.09.26		Pokémon has turned 30, and Target is set to cash in on the anniversary craze
17.09.26		Here's What a $500 Investment in SpaceX Stock Could Be Worth by 2030
17.09.26		Stellantis' $25 Billion Gamble: Can a Fresh and Balanced Strategy Spark a Turnaround in Its Profit Engine?
17.09.26		$1000 Invested In Raymond James Finl 10 Years Ago Would Be Worth This Much Today

Zurück | 1 | 2 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Misawa Hitachi Kokusai Electric Tower Tri-Hub International Sonnen

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	18.09.2026 06:32
Kaufwert:	EUR
	Hinzufügen Speichern

Chiome Bioscience Aktie

WKN DE: A1JTP0 / ISIN: JP3205350006

Chiome Bioscience Times and Sales (TOKIO)

Times and Sales

Analysen zu Chiome Bioscience Inc.

Weitere Meldungen